Tomoda H, McAlpine JB. Special issue dedicated to William Fenical: a pioneer in marine/marine-derived microbial chemistry. J Antibiot (Tokyo). 2020 Aug;73(8):488-489.
Nur EAA, Kobayashi K, Amagai A, Ohshiro T, Tomoda H. New Terpendole Congeners, Inhibitors of Sterol O-Acyltransferase, Produced by Volutella citrinella BF-0440. Molecules. 2020 Jul 6;25(13):3079.
Ohshiro T, Imuta S, Hijikuro I, Yagyu H, Takahashi T, Doi T, Ishibashi S, Tomoda H. The Anti-atherogenic Activity of Beauveriolide Derivative BVD327, a Sterol O-Acyltransferase 2-Selective Inhibitor, in Apolipoprotein E Knockout Mice. Biol Pharm Bull. 2020;43(6):951-958.
Ohshiro T, Morita H, Nur EAA, Hosoda K, Uchida R, Tomoda H. Voluhemins, new inhibitors of sterol O-acyltransferase, produced by Volutella citrinella BF-0440. J Antibiot (Tokyo). 2020 May 29.
Fukuda T, Nagai K, Yagi A, Kobayashi K, Uchida R, Yasuhara T, Tomoda H. Nectriatide, a Potentiator of Amphotericin B Activity from Nectriaceae sp. BF-0114. J Nat Prod. 2019 Oct 25;82(10):2673-2681.
Hosoda K, Koyama N, Kanamoto A, Tomoda H. Discovery of Nosiheptide, Griseoviridin, and Etamycin as Potent Anti-Mycobacterial Agents against Mycobacterium avium Complex. Molecules. 2019 Apr 16;24(8):1495.
Ohshiro T, Ohtawa M, Nagamitsu T, Matsuda D, Yagyu H, Davis MA, Rudel LL, Ishibashi S, Tomoda H. New pyripyropene A derivatives, highly SOAT2-selective inhibitors, improve hypercholesterolemia and atherosclerosis in atherogenic mouse models. J Pharmacol Exp Ther. 2015 Nov;355(2):299-307.
他多数